Harro, C., Perez-Sanz, J., Costich, T. L., Payne, K. K., Galindo, C. M. A., Gonzalez, R. A. C., … Conejo-Garcia, J. R. (2020). SATB1 as a novel therapeutic target for methyltransferase inhibitors against Cutaneous T Cell Lymphoma. In JOURNAL OF IMMUNOLOGY (Vol. 204).

Harro, Carly, Jairo Perez-Sanz, Tara Lee Costich, Kyle K. Payne, Carmen Maria Anadon Galindo, Ricardo A Chaurio Gonzalez, Subir Biswas, et al. “SATB1 as a novel therapeutic target for methyltransferase inhibitors against Cutaneous T Cell Lymphoma.” In JOURNAL OF IMMUNOLOGY, Vol. 204, 2020.

Harro C, Perez-Sanz J, Costich TL, Payne KK, Galindo CMA, Gonzalez RAC, et al. SATB1 as a novel therapeutic target for methyltransferase inhibitors against Cutaneous T Cell Lymphoma. In: JOURNAL OF IMMUNOLOGY. 2020.

Harro, Carly, et al. “SATB1 as a novel therapeutic target for methyltransferase inhibitors against Cutaneous T Cell Lymphoma.” JOURNAL OF IMMUNOLOGY, vol. 204, no. 1, 2020.

Harro C, Perez-Sanz J, Costich TL, Payne KK, Galindo CMA, Gonzalez RAC, Biswas S, Mandal G, Rigolizzo KE, Mine JA, Showe LC, Liu K, Rodriguez PC, Pinilla-Ibarz JL, Sokol L, Conejo-Garcia JR. SATB1 as a novel therapeutic target for methyltransferase inhibitors against Cutaneous T Cell Lymphoma. JOURNAL OF IMMUNOLOGY. 2020.